There is no published, peer-reviewed human clinical trial of subcutaneous or systemic GHK-Cu demonstrating efficacy for any outcome
doi:10.5021/ad.2016.28.4.438 Bobyntsev II, Chernysheva OI, Dolgintsev ME, Smakhtin MY, Belykh AE
Glutathione-S-transferase (GSTP) that participates in the conjugation of GSH to reactive cysteines (S-glutathionylation) seems to play an important role in idiopathic pulmonary fibrosis lung fibrogenesis, since GSTP immunoreactivity is increased in the lungs of idiopathic pulmonary fibrosis patients, notably within type II epithelial cells (128, 129)
Almaguer-Mederos, L
These thin needles minimize discomfort while adequately reaching the subcutaneous layer
Safety analyses included all participants who received at least one dose of the assigned intervention, with results summarized descriptively [1]